Irman Forghani, MD
Clinical Genetics (M.D.) · Miami, FLNPI 1427348549
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,252, more than ten times the $45 reported in 2019.
Across 93 payments — averaging $33.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Genetic Laboratories, Inc.$610
- Sanofi$310
- Merck$295
- Seagen Inc.$170
- Takeda Pharmaceuticals U.S.A., Inc.$168
- Tempus AI, Inc$135
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,07898%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 5 | $610 |
| Sanofi | 5 | $310 |
| Merck | 14 | $295 |
| Seagen Inc. | 1 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $168 |
| Tempus AI, Inc | 2 | $135 |
| Daiichi Sankyo Inc. | 5 | $128 |
| AbbVie | 1 | $116 |
| Incyte Corporation | 5 | $112 |
| Adaptive Biotechnologies Corporation | 5 | $97 |
| Intuitive Surgical | 1 | $94 |
| Genentech USA, Inc. | 4 | $89 |
| AstraZeneca(2 entities) | 3 | $87 |
| Pharmacosmos Therapeutics Inc. | 4 | $83 |
| Servier Pharmaceuticals LLC | 3 | $77 |
| Biomarin Pharmaceutical Inc. | 2 | $68 |
| Johnson & Johnson | 2 | $67 |
| Agios Pharmaceuticals, Inc. | 3 | $66 |
| AVEO Pharmaceuticals, Inc. | 3 | $62 |
| Eisai Inc. | 3 | $52 |
| Genmab U.S., Inc. | 2 | $46 |
| Pfizer | 2 | $34 |
| Stemline Therapeutics Inc. | 2 | $33 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Sobi, Inc | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $23 |
| Beone Medicines USA, Inc. | 1 | $19 |
| Pharmaand GmbH | 1 | $14 |
| Tolmar, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,146 in reported general payments places this provider in the 75th percentile of 37 clinical genetics (m.d.) providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other clinical genetics (m.d.) in Miami
- Parul JayakarMiami$82K
- Deborah BarbouthMiami$40K
- Sajel LalaMiami$2K
- Ana Marie Rodriguez BarretoMiami$1K
- Thelma SugranesMiami$1K
- Paul CardenasMiami$343
- Sofia CatenaMiami$229
- Willa ThorsonMiami$71
- Mustafa TekinMiami$52
- Nicholas BorjaMiami$41
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.